Novel centrosome protein, TCC52, is a cancer-testis antigen

Cancer Science

Volumn 99, Issue 11, 2008, Pages 2274-2279

  Li, Sichen ^a,b   Hu, Xiaohua ^a,b   Cui, Shuang ^a,b   He, Dacheng ^a,b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b Universities' Confederated Institute of Proteomics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PROTEIN TCC52; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; LARYNX CANCER; LUNG CANCER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR IMMUNITY;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CENTROSOME; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS; TESTIS;

EID: 55449086083     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00937.x     Document Type: Article

References (24)

1. Scanlan M, Simpson A, Old L. The cancer/testis genes: Review, standardization, and commentary. Cancer Immun 2004; 4: 1-15.
2. Old L. Cancer vaccines 2003: Opening address. Cancer Immun 2003, 3.
3. Scanlan M, Gure A, Jungbluth A, Old L, Chen Y. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32.
4. Old L. Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun 2001; 1: 1-7.
5. Fiszer D, Kurpisz M. Major histocompatibility complex expression on human, male germ cells: A review. Am J Reprod Immunol 1998; 40: 172-6.
6. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
7. Traversari C, Bruggen P, Eynde B et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992; 35: 145-52.
8. Stockert E, Jager E, Chen Y et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998; 187: 1349-54.
9. Yakirevich E, Sabo E, Lavie O, Mazareb S, Spagnoli G, Resnick M. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Clin Cancer Res 2003; 9: 6453-60.
10. Bornens M. Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 2002; 14: 25-34.
11. Boveri T. The Origin of Malignant Tumors. Baltimore, Maryland: Williams and Wilkins, 1929.
12. Wang X, Greenhalgh D, Jiang A et al. Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53172H mutant and p53-knockout mice after chemical carcinogenesis: Evidence for a gain of function. Mol Carcinog 1998; 23: 185-92.
13. Xia L, Li Y, Yang D et al. Identification of new centrosome proteins by autoimmune patient sera. Sci China C Life Sci 2007; 50: 194-202.
14. Nagase T, Kikuno R, Ohara O. Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins. DNA Res 2001; 8: 179-87.
15. Luo C, Xiao X, Liu D et al. CABYR is a novel cancer-testis antigen in lung cancer. Clin Cancer Res 2007; 13: 1288.
16. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-8.
17. Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 2003; 75: 663-70.
18. Guo D, Hu K, Lei Y, Wang Y, Ma T, He D. Identification and characterization of a novel cytoplasm protein ICF45 that is involved in cell cycle regulation. J Biol Chem 2004; 279: 53498.
19. Crew A, Clark J, Fisher C et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995; 14: 2333-40.
20. Yousef G, Kyriakopoulou L, Scorilas A et al. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker. Cancer Res 2001; 61: 7811-8.
21. Park S, Lim Y, Lee D et al. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. BBA-Gene Structure Expression 2003; 1625: 173-82.
22. Parmigiani R, Bettoni F, Vibranovski M et al. Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci USA 2006; 103: 18066.
23. Sugita Y, Wada H, Fujita S et al. NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Res 2004; 64 (6): 2199-204.
24. Jaeger E, Stockert E, Zidianakis Z et al. Humoral immune responses of cancer patients against 'Cancer-Testis' antigen NY-ESO-1: Correlation with clinical events. Int J Cancer 1999; 84: 506-10.